Order Article Reprints

Thangavel H, Angelis CD, Vasaikar S, Bhat R, Jolly MK, Nagi C, Creighton CJ, Chen F, Dobrolecki LE, George JT, et al. A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer. Journal of Clinical Medicine. 2019; 8(11):1772. https://doi.org/10.3390/jcm8111772

Thangavel, Hariprasad, Carmine De Angelis, Suhas Vasaikar, Raksha Bhat, Mohit Kumar Jolly, Chandandeep Nagi, Chad J. Creighton, Fengju Chen, Lacey E. Dobrolecki, Jason T. George, and et al. 2019. "A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer" Journal of Clinical Medicine 8, no. 11: 1772. https://doi.org/10.3390/jcm8111772

Thangavel, H., Angelis, C. D., Vasaikar, S., Bhat, R., Jolly, M. K., Nagi, C., Creighton, C. J., Chen, F., Dobrolecki, L. E., George, J. T., Kumar, T., Abdulkareem, N. M., Mao, S., Nardone, A., Rimawi, M., Osborne, C. K., Lewis, M. T., Levine, H., Zhang, B., ... Trivedi, M. V. (2019). A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer. Journal of Clinical Medicine, 8(11), 1772. https://doi.org/10.3390/jcm8111772